HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.
about
Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoIdentifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction networkStructural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBA quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture.Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryQuantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.HIV-1 Vpr and G2 cell cycle arrest.HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinantsJC virus T-antigen regulates glucose metabolic pathways in brain tumor cells.APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivoVif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 VifHepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.Gene expression profiling of CD4⁺ T cells in treatment-naive HIV, HCV mono- or co-infected ChineseHIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications.Genome guardian p53 and viral infections.Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells.Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translation.Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical modelHIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factorsGenome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection.Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.Viral internal ribosomal entry sites: four classes for one goal.HIV-1 Vif's capacity to manipulate the cell cycle is species-specific.Single-Cell Analysis of the Impact of Host Cell Heterogeneity on Infection with Foot-and-Mouth Disease Virus.p53 and the Viral Connection: Back into the Future ‡.
P2860
Q26851152-94C8B524-664D-4E32-A185-1520308F7D61Q28533728-0D1E26A8-0BA7-4D83-B169-ACC2DDB25B2EQ28540150-27686C56-254E-4C70-B448-1760031E0AC4Q30224621-3BDB59E6-DED2-4EED-9937-DA16D913C0DCQ33567848-2798EC60-5505-481A-807B-7B388837DADEQ33602923-82DE41FD-2838-4C9C-9A39-6B7E21359641Q33884000-B2B0A677-8835-445B-BD90-369105838C2AQ34059564-92411B6A-33D7-46FE-AAE9-25668E755C1EQ34230468-A0F4B4F5-56D6-45A5-A4A0-8B3183C08EE1Q34352429-54BDAB4F-974D-4282-B621-A3D18B9A6F05Q35067233-DC1158F1-A626-486B-8747-F5D8DE023684Q35076553-18815134-B7CC-4251-A3BA-BCFFF1EF778AQ35579416-292F726D-6EA1-4B39-80AF-FCB936C90487Q35764761-89D2E7FC-A025-4B13-8FE8-9879DEBC782BQ36181649-526E33ED-34B1-41FA-BA93-068EB163513CQ36395865-B43583F0-BC5A-40EE-9034-3E4530732C20Q36537806-FEAB6E45-EEE1-4CC6-8657-97962AD31A5CQ36619471-E37B8800-96FF-44DF-8710-8CCC7D7D701FQ37252567-60A4C486-D059-458C-9F1E-99AB66B74502Q37528045-877A09D0-EF34-4E49-A1CF-009195E3DEC2Q37619844-0607BBC9-FFCB-43E5-8657-98EF136A556BQ37970436-727846EB-3934-4944-A502-B35ACA4A044FQ38068825-0567B50A-949D-433A-9595-D6370D6DC0F2Q38739726-86F048B9-4293-4251-99E2-7FD81E4799F5Q38749301-8B1EAF8D-71EE-4BFC-A3B2-FBDAFC2F8FC5Q38765818-11732BAD-F31D-4240-9561-06B5E7C22A99Q39241455-BCCD1671-3A6C-4A0B-A291-D3A91D432ED2Q39390501-93ED8D04-35F4-452E-A762-1E4A73C87D96Q39463408-B8A908CD-FA43-4134-A809-E02DF4587A0DQ39669210-597182BB-194B-4770-802F-50F7CADA4AF8Q45325964-60298939-3DD0-4CE2-95FB-A69EF1B80344Q47343124-2C55647F-0056-48C8-BADF-8F4FD740A7C7Q47555826-9198E9C2-7E6E-4E8F-832C-53E1C9C8CFA5Q52695026-0452FF98-F51E-4570-8814-3A467605FC35Q55084411-737E81DF-4E81-4744-89C8-56E44FEA7F35
P2860
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@ast
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@en
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@nl
type
label
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@ast
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@en
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@nl
prefLabel
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@ast
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@en
HIV-1 viral infectivity factor ...... ly regulate viral replication.
@nl
P2093
P2860
P356
P1476
HIV-1 viral infectivity factor ...... ely regulate viral replication
@en
P2093
Akifumi Takaori-Kondo
Hiroshi Kondoh
Katsuhiro Io
Kotaro Shirakawa
Masanobu Shinohara
Masashi Matsui
Masayuki Kobayashi
Naoko Misawa
Takashi Uchiyama
Yoshio Koyanagi
P2860
P304
20798-20803
P356
10.1073/PNAS.1008076107
P407
P577
2010-11-11T00:00:00Z